215 related articles for article (PubMed ID: 32311600)
1. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.
Yoon S; Cao M; Aghdam N; Shabsovich D; Kahlon S; Ballas L; Collins S; Steinberg ML; Kishan AU
Radiother Oncol; 2020 Jul; 148():44-50. PubMed ID: 32311600
[TBL] [Abstract][Full Text] [Related]
2. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
[TBL] [Abstract][Full Text] [Related]
3. Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial.
Cao M; Gao Y; Yoon SM; Yang Y; Sheng K; Ballas LK; Basehart V; Sachdeva A; Felix C; Low DA; Steinberg ML; Kishan AU
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199881
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.
Gawish A; Chughtai AA; Eble MJ
Strahlenther Onkol; 2019 May; 195(5):383-392. PubMed ID: 30334066
[TBL] [Abstract][Full Text] [Related]
5. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
[TBL] [Abstract][Full Text] [Related]
6. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note.
Jmour O; Benna M; Champagnol P; Ben Mrad M; Hamrouni A; Obeid L; Lahmamssi C; Bousarsar A; Vial N; Rehailia-Blanchard A; Sotton S; Lan M; Langrand-Escure J; Vallard A; Magné N
Radiat Oncol; 2020 Apr; 15(1):85. PubMed ID: 32307017
[TBL] [Abstract][Full Text] [Related]
7. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?
Byun DJ; Gorovets DJ; Jacobs LM; Happersett L; Zhang P; Pei X; Burleson S; Zhang Z; Hunt M; McBride S; Kollmeier MA; Zelefsky MJ
Radiat Oncol; 2020 Oct; 15(1):239. PubMed ID: 33066781
[TBL] [Abstract][Full Text] [Related]
8. The impact of rectal and bladder variability on target coverage during post-prostatectomy intensity modulated radiotherapy.
Bell LJ; Cox J; Eade T; Rinks M; Kneebone A
Radiother Oncol; 2014 Feb; 110(2):245-50. PubMed ID: 24560757
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
[TBL] [Abstract][Full Text] [Related]
10. Intra-fractional geometric and dose/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy.
Gao Y; Yoon S; Ma TM; Yang Y; Sheng K; Low DA; Ballas L; Steinberg ML; Kishan AU; Cao M
Phys Imaging Radiat Oncol; 2024 Apr; 30():100573. PubMed ID: 38585371
[TBL] [Abstract][Full Text] [Related]
11. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
12. Volumetric-based image guidance is superior to marker-based alignments for stereotactic body radiotherapy of prostate cancer.
Li W; Lu L; Stephans KL; Sharma N; Vassil A; Shen ZL; Stockham A; Djemil T; Tendulkar RD; Xia P
J Appl Clin Med Phys; 2018 Mar; 19(2):198-203. PubMed ID: 29450961
[TBL] [Abstract][Full Text] [Related]
13. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients.
Diot Q; Olsen C; Kavanagh B; Raben D; Miften M
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):623-32. PubMed ID: 20643519
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.
Pearson D; Gill SK; Campbell N; Reddy K
J Appl Clin Med Phys; 2016 Nov; 17(6):107-117. PubMed ID: 27929486
[TBL] [Abstract][Full Text] [Related]
16. Does Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?
Elakshar S; Tsui JMG; Kucharczyk MJ; Tomic N; Fawaz ZS; Bahoric B; Papayanatos J; Chaddad A; Niazi T
Technol Cancer Res Treat; 2019 Jan; 18():1533033819831962. PubMed ID: 30782085
[TBL] [Abstract][Full Text] [Related]
17. Does rectum and bladder dose vary during the course of image-guided radiotherapy in the postprostatectomy setting?
Akin M; Öksüz DC; Iktueren B; Ambarcioglu P; Karacam S; Koca S; Dincbas FÖ
Tumori; 2014; 100(5):529-35. PubMed ID: 25343548
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
Jones BL; Gan G; Diot Q; Kavanagh B; Timmerman RD; Miften M
Med Phys; 2012 Jun; 39(6):3080-8. PubMed ID: 22755693
[TBL] [Abstract][Full Text] [Related]
19. Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.
Kishan AU; Lamb JM; Jani SS; Kang JJ; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):832-9. PubMed ID: 25752398
[TBL] [Abstract][Full Text] [Related]
20. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
